Velsera
Solutions for Clinical Genomics Implementation, Reporting, and Multimodal Data Analysis
Boston, United States · Founded 2023
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2023
- Business Model
- B2B
- Website
- velsera.com
- Last Round
- Private EquityJan 2023
- Rounds
- 1
About
AI-enhanced software and services accelerating precision medicine discovery and delivery.
Summary
Velsera is a Biotech company based in Boston, United States, founded in 2023. Its most recent funding was a Private Equity round in Jan 2023. Investors include Summa Group.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...